Filing Flows › InspireMD (NSPR) › Q2 2026 › vs Q2 2025
InspireMD (NSPR) Q2 2026 vs Q2 2025 (year over year)
InspireMD's revenue fell $7K (-0.4%) from $1.8M in Q2 2025 to $1.8M in Q2 2026.
InspireMD, Q2 2026: revenue $1.8M (-0.4% year over year), operating margin -815.6%, net loss $14.3M, operating cash flow −$10.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $1.8M | −$7K | -0.4% |
| Other income, net | $121K | −$132K | $253K | — |
| Net loss | $14.3M | $13.2M | $1.2M | +9% |
| Costs & expenses | $16.2M | $14.9M | $1.3M | +9% |
| Operating costs | $16.2M | $14.8M | $1.4M | +10% |
| Research & development | $4.3M | $3.8M | $461K | +12% |
| Sales & marketing | $5.2M | $4.2M | $1.0M | +25% |
| General & admin | $4.2M | $5.3M | −$1.2M | -22% |
| Operating cash sources | $14.3M | $13.2M | $1.2M | +9% |
| Depreciation | $158K | $107K | $51K | +48% |
| Share-based compensation | $2.2M | $3.2M | −$993K | -31% |
| Working capital & other | $1.1M | $1.5M | −$447K | -30% |
| Cash used in operations | $10.9M | $8.3M | $2.6M | +31% |
| Net loss absorbed | $14.3M | $13.2M | $1.2M | +9% |
Questions
How much did InspireMD's revenue grow year over year in Q2 2026?
InspireMD's revenue fell $7K (-0.4%) from $1.8M in Q2 2025 to $1.8M in Q2 2026.